Filter
New

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

for
Atrial Fibrillation
Location: Manhattan NY, Montreal, Haddon Heights NJ, Littleton CO,
Sponsor: Milestone Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06716021

Phase3, Recruiting
New

Pedal Pump Clinical Trial on Edema V2

for
Lower Extremity Edema, Lower Extremity Edema Chronic,
Location: Tulsa OK
Sponsor: Hillcrest

Sex: All

Age: 18+

Code: NCT07809516

Recruiting
New

Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment

for
Venous Leg Ulcers (VLUs)
Location: Fort Wayne IN
Sponsor: Feeltect Limited

Sex: All

Age: 18+

Code: NCT07152717

Recruiting
New

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

for
HIV
Location: New York NY, Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT07665372

Recruiting
New

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

for
Intracranial Venous Blood, Brain Cancers, Liquid Biopsy,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07467109

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: The Bronx NY, New York NY, Bel Air MD, Glen Burnie MD,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase3, Recruiting
Active & ResponsiveNew

Study of Oral Food Challenge Biomarkers (SAFER)

for
Allergy
Location: New York NY, Baltimore MD, Chapel Hill NC, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 17

Code: NCT07279467

Recruiting
Active & ResponsiveNew

Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis

for
Clinical High Risk for Psychosis (CHR)
Location: Toronto
Sponsor: Centre for Addiction and Mental Health

Sex: All

Age: 14 - 35

Code: NCT06928935

Recruiting
New

A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines

for
Glabellar Lines
Location: Chestnut Hill MA, Wilmington NC, Nashville TN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07756580

Phase1, Recruiting
Active & ResponsiveNew

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 4 - 34

Code: NCT07216391

Phase2, Recruiting
New

Breast Artery Calcification (BAC) and Female Cardiovascular Disease

for
Cardiovascular Health Risk Communication,
Location: Manhasset NY
Sponsor: Northwell Health

Sex: Female

Age: 55 - 65

Code: NCT07809932

Recruiting
New

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

for
Secondary Immune Deficiency
Location: Bethesda MD, Coral Springs FL
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07648264

Phase3, Recruiting
Active & ResponsiveNew

Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina

for
Opioid Use Disorder, Digital Health Intervention, Telemedicine,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT07810322

Recruiting
New

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

for
ACS (Acute Coronary Syndrome), Hyperlipidemia, Dyslipidemia,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT07685639

Recruiting
Active & ResponsiveNew

Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy

for
Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Location: Pasadena CA
Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation

Sex: Female

Age: 35 - 55

Code: NCT07810504

Recruiting
New

Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer

for
Infertility
Location: Bedford TX
Sponsor: Kevin Doody

Sex: Female

Age: 18 - 35

Code: NCT07801105

Recruiting
Active & ResponsiveNew

Cannabis (THC vs. CBD) in Multiple Sclerosis

for
Multiple Sclerosis
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 26 - 59

Code: NCT06261489

Phase2, Recruiting
New

Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect

for
Childhood Apraxia of Speech
Location: Hempstead NY, New York NY
Sponsor: New York University

Sex: All

Age: 3 - 12

Code: NCT07526246

Recruiting
New

Longevity Metrics AI/ML Development Study

for
Aging, Mortality, Cardiovascular Disease Prevention,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07808619

Recruiting
Active & ResponsiveNew

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

for
Chronic Kidney Disease
Location: Toronto, Waterloo, Minneapolis MN, Arlington TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07753993

Phase3, Recruiting